Summit Corporation PLC: Director/PDMR Shareholding

              Summit Corporation PLC: Director/PDMR Shareholding

Summit Corporation plc
('Summit' or 'the Company')
DIRECTOR SHAREHOLDINGS

Oxford, UK, 30 July 2014 - Summit (AIM: SUMM), the drug discovery and
development company advancing therapies for Duchenne Muscular Dystrophy
('DMD') and C. difficile infection, announces that it received notification
that, on 29 July 2014, Glyn Edwards, Chief Executive Officer of the Company,
acquired 30,000 ordinary shares of 1 penny each ("Ordinary Shares") in the
Company at a price of 104.5 pence per Ordinary Share.

Following this transaction, Glyn Edwards holds 233,333 Ordinary Shares,
representing 0.57% of the current issued share capital of the Company.

                                   - END -
                               Notes to Editors
                                 About Summit
Summit is an Oxford, UK based drug discovery and development company targeting
 high-value areas of unmet medical need including Duchenne Muscular Dystrophy
 and C. difficile infection. Summit is quoted on the AIM market of the London
Stock Exchange and trades under the ticker symbol SUMM. Further information is
     available at www.summitplc.com and Summit can be followed on Twitter
                                (@summitplc).

For more information, please contact:

Summit                               Tel: +44 (0)1235 443 951
Glyn Edwards / Richard Pye
Cairn Financial Advisers LLP         Tel: +44 (0)20 7148 7900
(Nominated Adviser)
Liam Murray / Tony Rawlinson
N+1 Singer                           Tel: +44 (0)20 7496 3000
(Broker)
Aubrey Powell / Jen Boorer
Peckwater PR                         Tel: +44 (0)7879 458 364
(Financial public relations, UK)     tarquin.edwards@peckwaterpr.co.uk
Tarquin Edwards
MacDougall Biomedical Communications Tel: +1 781-235-3060
(US media contact)
Michelle Avery

------------------------------------------------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf
of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Summit Corporation PLC via Globenewswire
HUG#1842731
 
Press spacebar to pause and continue. Press esc to stop.